TRU-015
- Generic Name
- TRU-015
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- -
- CAS Number
- 1169717-01-4
- Unique Ingredient Identifier
- T0N62K2M2Y
- Indication
Investigated for use/treatment in lymphoma (unspecified) and rheumatoid arthritis.
- Associated Conditions
- -
- Associated Therapies
- -
Study Evaluating 2 Dosing Regimens Of TRU-015 In Rheumatoid Arthritis
Phase 2
Terminated
- Conditions
- Interventions
- First Posted Date
- 2008-03-13
- Last Posted Date
- 2013-03-11
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 222
- Registration Number
- NCT00634933
- Locations
- 🇷🇸
Pfizer Investigational Site, Niska Banja, Serbia
Study of TRU-015 in Subjects With Membranous Nephropathy Secondary to Systemic Lupus Erythematosus
- First Posted Date
- 2007-05-28
- Last Posted Date
- 2008-05-08
- Lead Sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer
- Target Recruit Count
- 20
- Registration Number
- NCT00479622
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath